Monitoring tyrosine kinase inhibitors (TKI) response in chronic myeloid leukemia (CML) patients by longitudinal collection and evaluation of omics data

Gender
Any

Age Group
Any

At a Glance

IRB#IRB13-0716

Lead PhysicianRong Huang

Collaborator(s)N/A

EligibilityRecruiting